Answers are grounded in this paper and cite their sources.
Substituted 4‐oxoquinoline‐3‐ ( 1a ) and 4‐oxo‐1,8‐naphthyridine‐3‐ ( 1b ) carboxylic acids are clinically useful antibacterial agents exerting their activity by inhibiting the subunit A of DNA gyrase. Recently, pyrimido‐[1,6‐ a ]benzimidazoles 2 were found to be a new class of inhibitors of this enzyme. As, in 1 , replacement of C(8) by the N‐atom was shown beneficial for the biological properties, a synthesis of the corresponding aza analogues of 2 has been carried out. The synthesis, DNA gyrase inhibitory activity, and in vitro antibacterial activity of the target compounds 16–19 are reported.
No takes yet. Share an insight, caveat, or question.
ŠRAGA et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: